These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39035715)

  • 1. Green synthesis,
    Akhavan M; Esam Z; Mirshafa A; Lotfi M; Pourmand S; Ashori F; Rabani M; Ekbatani G; Tourani S; Beheshti R; Keshavarzian Z; Ghanbarimasir Z; Bekhradnia A
    RSC Adv; 2024 Jul; 14(32):22916-22938. PubMed ID: 39035715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green synthesis, anti-proliferative evaluation, docking, and MD simulations studies of novel 2-piperazinyl quinoxaline derivatives using hercynite sulfaguanidine-SA as a highly efficient and reusable nanocatalyst.
    Esam Z; Akhavan M; Mirshafa A; Bekhradnia A
    RSC Adv; 2023 Aug; 13(36):25229-25245. PubMed ID: 37622018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green Synthesis, Biological Activity Evaluation, and Molecular Docking Studies of Aryl Alkylidene 2, 4-thiazolidinedione and Rhodanine Derivatives as Antimicrobial Agents.
    Akhavan M; Foroughifar N; Pasdar H; Bekhradnia A
    Comb Chem High Throughput Screen; 2019; 22(10):716-727. PubMed ID: 31775594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-assisted one-pot green synthesis of new N- substituted-5-arylidene-thiazolidine-2,4-dione-isoxazoline derivatives using NaCl/Oxone/Na
    Thari FZ; Tachallait H; El Alaoui NE; Talha A; Arshad S; Álvarez E; Karrouchi K; Bougrin K
    Ultrason Sonochem; 2020 Nov; 68():105222. PubMed ID: 32585575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Nasser M; Abulkhair HS; El-Hddad SSA
    Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000279. PubMed ID: 33073374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Evaluation of a New Series of Arylidene Indanones as Potential Anticancer Agents.
    Özdemir A; Gökbulut S; Sever B; Çiftçi GA; Altıntop MD
    Anticancer Agents Med Chem; 2018; 18(10):1394-1404. PubMed ID: 29210665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents.
    Azizmohammadi M; Khoobi M; Ramazani A; Emami S; Zarrin A; Firuzi O; Miri R; Shafiee A
    Eur J Med Chem; 2013 Jan; 59():15-22. PubMed ID: 23202485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARgamma ligands.
    Barros CD; Amato AA; de Oliveira TB; Iannini KB; Silva AL; Silva TG; Leite ES; Hernandes MZ; Alves de Lima Mdo C; Galdino SL; Neves Fde A; Pitta Ida R
    Bioorg Med Chem; 2010 Jun; 18(11):3805-11. PubMed ID: 20471839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-(4-Methoxybenzylidene)thiazolidine-2,4-dione-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
    El-Adl K; Sakr H; Nasser M; Alswah M; Shoman FMA
    Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000079. PubMed ID: 32515896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, In Silico Studies, and Antioxidant and Tyrosinase Inhibitory Potential of 2-(Substituted Phenyl) Thiazolidine-4-Carboxamide Derivatives.
    Zargaham MK; Ahmed M; Akhtar N; Ashraf Z; Abdel-Maksoud MA; Aufy M; Nadeem H
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, photophysical properties, anticancer evaluation, and molecular docking studies of new pyrimidine linked 4-arylidene-thiazolidin-4-ones as potent anticancer agents.
    Jame R
    Luminescence; 2024 Jan; 39(1):e4672. PubMed ID: 38286597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and molecular docking of novel 1,3,4-substituted-thiadiazole derivatives as potential anticancer agent.
    Shaikh SA; Wakchaure SN; Labhade SR; Kale RR; Alavala RR; Chobe SS; Jain KS; Labhade HS; Bhanushali DD
    BMC Chem; 2024 Jun; 18(1):119. PubMed ID: 38937800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studies.
    Elkady H; Mahdy HA; Taghour MS; Dahab MA; Elwan A; Hagras M; Hussein MH; Ibrahim IM; Husein DZ; Elkaeed EB; Alsfouk AA; Metwaly AM; Eissa IH
    Biochim Biophys Acta Gen Subj; 2024 Jun; 1868(6):130599. PubMed ID: 38521471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 2-Substituted 4-Arylidene-5(4H)-oxazolones as Potential Cytotoxic Agents in the Presence of Lemon Juice as a Biocatalyst.
    Prasad MG; Lakshmi CV; Katari NK; Anand K; Pal M; Jonnalagadda SB
    Comb Chem High Throughput Screen; 2019; 22(9):625-634. PubMed ID: 31696809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
    El-Adl K; Sakr H; El-Hddad SSA; El-Helby AA; Nasser M; Abulkhair HS
    Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000491. PubMed ID: 33788290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, cytotoxic assessment, and molecular docking studies of 2,6-diaryl-substituted pyridine and 3,4- dihydropyrimidine-2(1H)-one scaffolds.
    Hosseinzadeh Z; Razzaghi-Asl N; Ramazani A; Aghahosseini H; Ramazani A
    Turk J Chem; 2020; 44(1):194-213. PubMed ID: 33488152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, in silico studies and biological evaluation of 5-((
    Kumar H; Deep A; Marwaha RK
    BMC Chem; 2020 Dec; 14(1):25. PubMed ID: 32266332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
    Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
    Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SO
    Kalantari F; Esmailipour H; Ahankar H; Ramazani A; Aghahosseini H; Kaszubowski O; Ślepokura K
    ACS Omega; 2023 Jul; 8(29):25780-25798. PubMed ID: 37521605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.